Paramount Chemi-Quip Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 2.66 M
- Company Age 53 Year, 10 Months
- Last Filing with ROC 31 Mar 2010
- Open Charges ₹ 3.32 Cr
About Paramount Chemi-Quip
Paramount Chemi-Quip Private Limited (PCPL) was founded in India on 22 April 1971 and has a glorious history of 53 years and ten months.Its registered office is in Mumbai, Maharashtra.
The Company is engaged in the Public Administration Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2010. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.66 M.
The company currently has active open charges totaling ₹3.32 Cr.
Monica Fernandes and Sarvdeep Paintal serve as directors at the Company.
Company Details
- Location Mumbai, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U99999MH1971PTC015120
- Company No.
015120
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Apr 1971
- Date of AGM
30 Sep 2010
- Date of Balance Sheet
31 Mar 2010
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Paramount Chemi-Quip?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Monica Fernandes  | Director | 05-Feb-2007 | Current |
| Sarvdeep Paintal | Director | 23-Jul-1980 | Current |
Financial Performance of Paramount Chemi-Quip.
Enhance accessibility to Paramount Chemi-Quip's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Paramount Chemi-Quip?
Unlock access to Paramount Chemi-Quip's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹3.32 Cr
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 3.32 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Nov 2000 | Canara Bank | ₹0.60 M | Open |
| 29 Dec 1999 | Canara Bank | ₹2.43 Cr | Open |
| 30 Aug 1998 | Canara Bank | ₹0.55 M | Open |
| 16 May 1997 | Canara Bank | ₹6.20 M | Open |
| 24 Apr 1996 | Canara Bank | ₹1.00 M | Open |
How Many Employees Work at Paramount Chemi-Quip?
Unlock and access historical data on people associated with Paramount Chemi-Quip, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Paramount Chemi-Quip, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Paramount Chemi-Quip's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.